|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Regional Respiratory Centre (Drs. Leggett and Heaney, and Mr. Gamble), Belfast City Hospital; and Esophageal Laboratory (Dr. Johnston and Ms. Mills), Royal Group Hospitals, Belfast, UK.
Correspondence to: Liam Heaney, MD, Regional Respiratory Centre, Level 8, Belfast City Hospital, Lisburn Rd, Belfast, BT97AB, UK; e-mail: Liam.Heaney{at}bch.n-i.nhs.uk
Study objectives: To determine the prevalence of gastroesophageal reflux disease (GERD)both symptoms and objective evidenceusing 24-h dual-probe pH monitoring in difficult asthma, and the relationship between the presence and treatment of GERD to clinical outcome.
Design and setting: As part of a systematic evaluation protocol, 68 subjects with difficult-to-control asthma attending a difficult asthma clinic were referred for dual-probe ambulatory pH esophageal monitoring.
Results: Esophageal probe data were available in 52 patients (76%) with difficult asthma. The prevalence of GERD/GERD-associated asthma symptoms was 75% (39 of 52 patients; 95% confidence interval [CI], 63 to 84.7%). The prevalence of GERD as evidenced by an abnormal pH profile at the distal esophageal probe was 55% (29 of 52 patients; 95% CI, 40 to 69%). The prevalence of GERD at the proximal probe was 34.6% (18 of 52 patients; 95% CI, 23.6 to 51%). The prevalence of GERD was similar in asthmatic subjects who responded to intervention and those who remained difficult to control (therapy resistant). Asymptomatic GERD was present in 9.6% (5 of 52 patients); 16% of cough episodes correlated with acid reflux.
Conclusions: In difficult-to-control asthma, GERD is common, but identification and treatment of GERD do not appear to relate to improvement in asthma control in this population.
Key Words: difficult asthma gastroesophageal reflux disease therapy-resistant asthma
This article has been cited by other articles:
![]() |
D.-W. Perng, K.-T. Chang, K.-C. Su, Y.-C. Wu, M.-T. Wu, W.-H. Hsu, C.-M. Tsai, and Y.-C. Lee Exposure of Airway Epithelium to Bile Acids Associated With Gastroesophageal Reflux Symptoms: A Relation to Transforming Growth Factor-{beta}1 Production and Fibroblast Proliferation Chest, November 1, 2007; 132(5): 1548 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kostikas, A. I. Papaioannou, K. I. Gourgoulianis, C. J. Etzel, S. Kachroo, H. Yanai, H. Yoshida, N. Tada, B. C. Jacobson, and C. A. Camargo Jr. BMI and Gastroesophageal Reflux in Women N. Engl. J. Med., August 24, 2006; 355(8): 848 - 850. [Full Text] [PDF] |
||||
![]() |
C. Butler and L. G. Heaney Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur. Respir. J., June 1, 2006; 27(6): 1324 - 1325. [Full Text] [PDF] |
||||
![]() |
S. E. Wenzel and R. Covar Update in asthma 2005. Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706. [Full Text] [PDF] |
||||
![]() |
S. Saglani, A. G. Nicholson, M. Scallan, I. Balfour-Lynn, M. Rosenthal, D. N. Payne, and A. Bush Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur. Respir. J., January 1, 2006; 27(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |